Related Experiment Video
Updated: Feb 6, 2026

06:51
A Preclinical Murine Model of Hepatic Metastases
Published on: September 27, 2014
30.4K
Hepatic Metastases From Prostatic Adenocarcinoma Without Elevated 18F-Choline Activity
Clinical Nuclear Medicine
|August 29, 2018
Summary
F-fluorocholine PET/CT may miss prostate cancer liver metastases. This pitfall, likely due to partial volume effects, requires careful interpretation alongside other imaging and pathology.
Area of Science:
- Nuclear Medicine
- Oncology
- Radiology
Background:
- Prostate cancer recurrence often requires advanced imaging for detection.
- F-fluorocholine (FCH) PET/CT is utilized for staging and detecting biochemical recurrence.
- Accurate localization of metastatic disease is crucial for treatment planning.
Observation:
- A 69-year-old man with biochemical recurrence of prostate cancer underwent FCH PET/CT.
- Two hepatic lesions showed no FCH uptake but increased in size on serial imaging.
- MRI revealed peripheral contrast enhancement in these lesions, suggestive of metastasis.
Findings:
- Histopathology confirmed the hepatic lesions as prostate adenocarcinoma metastasis.
- FCH PET/CT demonstrated a lack of radiotracer uptake in the liver metastasis.
- This negative finding on FCH PET/CT is attributed to a partial volume effect.
Implications:
- This case illustrates a potential pitfall in FCH PET/CT interpretation for prostate cancer.
- Necrotic centers and high liver uptake may obscure metastatic lesions on FCH PET/CT.
- Correlating FCH PET/CT findings with MRI and histopathology is essential for accurate diagnosis.
Related Concept Videos
Freezing Point Depression and Boiling Point Elevation
40.3K
Boiling Point Elevation
The boiling point of a liquid is the temperature at which its vapor pressure is equal to ambient atmospheric pressure. Since the vapor pressure of a solution is lowered due to the presence of nonvolatile solutes, it stands to reason that the solution’s boiling point will subsequently be increased. Vapor pressure increases with temperature, and so a solution will require a higher temperature than will pure solvent to achieve any given vapor pressure, including one...
The boiling point of a liquid is the temperature at which its vapor pressure is equal to ambient atmospheric pressure. Since the vapor pressure of a solution is lowered due to the presence of nonvolatile solutes, it stands to reason that the solution’s boiling point will subsequently be increased. Vapor pressure increases with temperature, and so a solution will require a higher temperature than will pure solvent to achieve any given vapor pressure, including one...
40.3K
Elevation of Intermediate Points on Vertical Curves
293
Vertical curves are essential in roadway design because they provide smooth transitions between varying roadway grades. Designing vertical curves involves calculating intermediate elevations and identifying the curve's highest or lowest point, which is essential for optimal roadway performance.Intermediate elevations on a vertical curve are determined using the tangent offset method. This method considers the initial elevation at the start of the curve, the grades, and the curve's geometry. The...
293
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
234
In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
234
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
281
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
281
Hepatic Portal System
6.0K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
6.0K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
247
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
247

